MWM
IDNA icon

Mission Wealth Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Mission Wealth Management’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$201K Buy
+5,947
New +$178K ﹤0.01% 1032

Other funds holding IDNA

AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PCA
Prosperity Capital Advisors Westlake, Ohio $2.03B AUM 23.67% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
M
MATAURO New York $756M AUM 20.74% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
VR
Vision Retirement Ridgewood, New Jersey $414M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Mission Wealth Management's IDNA Position: Q2 2026 in Review

Mission Wealth Management opened a new position in iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2026: 5,947 shares worth $201K. The stake represents ﹤0.01% of the portfolio and ranks #1032 among its holdings.

13 funds tracked by Wall St. Rank hold IDNA as of Q2 2026.

  • Mission Wealth Management held 5,947 shares of iShares Genomics Immunology and Healthcare ETF worth $201K as of Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF was a new Mission Wealth Management position in Q2 2026.
  • iShares Genomics Immunology and Healthcare ETF made up ﹤0.01% of Mission Wealth Management's portfolio in Q2 2026, its #1032 holding.
  • 13 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2026.

Based on Mission Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.